Hi there,

This month, Democracy Now! marks 29 years of fearless independent journalism. Presidents have come, gone and come back again, but Democracy Now! remains, playing the same critical role in our democracy: shining a spotlight on corporate and government abuses of power and raising up the voices of scholars, advocates, scientists, activists, artists and ordinary people working for a more peaceful and just world. If our journalism is important to you, please donate today in honor of our 29th anniversary. Every dollar makes a difference. Thank you so much.

Democracy Now!

Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

WHO Approves Use of First-Ever Vaccine Against Malaria

HeadlineOct 07, 2021

The World Health Organization has endorsed a first-of-its-kind vaccine against malaria for children in sub-Saharan Africa. The WHO said the vaccine proved to be safe and reduced severe malaria by 30% in children enrolled in a pilot program in Ghana, Kenya and Malawi. WHO chief Tedros Adhanom Ghebreyesus called the vaccine a major victory in the fight against one of the world’s worst infectious diseases.

Tedros Adhanom Ghebreyesus: “This long-awaited malaria vaccine is a breakthrough for science, child health and malaria control. Using this vaccine in addition to existing tools to prevent malaria could save tens of thousands of young lives each year.”

It’s the first vaccine ever approved for use against a parasitic disease. Malaria claims the lives of about a half a million people each year, half of whom are children in Africa.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top